CLGN Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: CollPlant

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

15 days ago - By: CollPlant

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

19 days ago - By: CollPlant

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

a month ago - By: Benzinga - Mentions: NBY APDN CANF ARTL ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

a month ago - By: CollPlant

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

2 months ago - By: Benzinga

Analyst Expectations For CollPlant Biotechnologies's Future

2 months ago - By: CollPlant

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

2 months ago - By: CollPlant

CollPlant to Present at the 2025 International Conference on Biofabrication

2 months ago - By: CollPlant

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

3 months ago - By: CollPlant

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

4 months ago - By: CollPlant

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

5 months ago - By: CollPlant

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

5 months ago - By: CollPlant

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

5 months ago - By: CollPlant

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

5 months ago - By: CollPlant

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

6 months ago - By: CollPlant

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

8 months ago - By: CollPlant

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

8 months ago - By: CollPlant

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

a year ago - By: CollPlant - Mentions: SSYS

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

a year ago - By: CollPlant

COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock News

CLGN Latest News, Press Relases and Analysis

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

Analyst Expectations For CollPlant Biotechnologies's Future

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

CollPlant to Present at the 2025 International Conference on Biofabrication

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION